Hodges Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-218,625
| Closed | -$13.1M | – | 266 |
|
|
2018
Q2 | $13.1M | Sell |
218,625
-57,050
| -21% | -$3.41M | 0.96% | 28 |
|
|
2018
Q1 | $12.6M | Sell |
275,675
-28,320
| -9% | -$1.3M | 1% | 28 |
|
|
2017
Q4 | $12.1M | Sell |
303,995
-24,950
| -8% | -$994K | 0.89% | 37 |
|
|
2017
Q3 | $13.2M | Sell |
328,945
-70,595
| -18% | -$2.82M | 0.89% | 39 |
|
|
2017
Q2 | $17.2M | Buy |
+399,540
| New | +$17.2M | 1.02% | 33 |
|
|
2016
Q4 | – | Sell |
-8,900
| Closed | -$220K | – | 288 |
|
|
2016
Q3 | $220K | Sell |
8,900
-9,800
| -52% | -$242K | 0.01% | 255 |
|
|
2016
Q2 | $381K | Sell |
18,700
-9,300
| -33% | -$189K | 0.02% | 215 |
|
|
2016
Q1 | $427K | Sell |
28,000
-302,380
| -92% | -$4.61M | 0.02% | 210 |
|
|
2015
Q4 | $4.44M | Sell |
330,380
-19,130
| -5% | -$257K | 0.18% | 99 |
|
|
2015
Q3 | $4.9M | Sell |
349,510
-108,460
| -24% | -$1.52M | 0.2% | 102 |
|
|
2015
Q2 | $7.78M | Buy |
+457,970
| New | +$7.78M | 0.28% | 100 |
|